Q3 2026 13F filing
Updated 6 days ago148 disclosed positions worth $780.5M
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | V VIKING THERAPEUTICS INC | $44.4M | 1.36M | 5.69% | — |
| 2 | C BRISTOL-MYERS SQUIBB CO | $37.4M | 600.0K | 4.80% | — |
| 3 | V VIKING THERAPEUTICS INC | $37.1M | 1.14M | 4.76% | — |
| 4 | ? N/A VIKING THERAPEUTICS INC | $32.6M | 1.00M | 4.18% | — |
| 5 | K KODIAK SCIENCES INC | $28.2M | 297.0K | 3.61% | — |
| 6 | U UNITED THERAPEUTICS CORP DEL | $25.7M | 47.5K | 3.30% | — |
| 7 | U UNITED THERAPEUTICS CORP DEL | $25M | 46.2K | 3.21% | — |
| 8 | B BIONTECH SE | $24.6M | 250.0K | 3.15% | — |
| 9 | K KODIAK SCIENCES INC | $23.9M | 251.7K | 3.06% | — |
| 10 | C BRISTOL-MYERS SQUIBB CO | $20.6M | 330.6K | 2.64% | — |
| 11 | C COGENT BIOSCIENCES INC | $20.6M | 641.9K | 2.63% | — |
| 12 | G GENMAB A/S | $18.5M | 518.1K | 2.37% | — |
| 13 | K KYMERA THERAPEUTICS INC | $18M | 160.9K | 2.30% | — |
| 14 | A ABIVAX SA | $17.7M | 178.4K | 2.27% | — |
| 15 | B BRIDGEBIO PHARMA INC | $16.4M | 250.0K | 2.11% | — |
| 16 | S SUMMIT THERAPEUTICS INC | $16.2M | 960.2K | 2.08% | — |
| 17 | B BIOMARIN PHARMACEUTICAL INC | $15.3M | 255.4K | 1.96% | — |
| 18 | R REVOLUTION MEDICINES INC | $14.4M | 70.0K | 1.84% | — |
| 19 | N NOVARTIS AG | $14.3M | 100.0K | 1.83% | — |
| 20 | V VIKING THERAPEUTICS INC | $14.1M | 433.2K | 1.81% | — |
| 21 | G GRAIL INC | $14M | 100.0K | 1.80% | — |
| 22 | A ABIVAX SA | $13.6M | 137.7K | 1.75% | — |
| 23 | S SUMMIT THERAPEUTICS INC | $13.6M | 801.4K | 1.74% | — |
| 24 | I INCYTE CORP | $12.8M | 105.4K | 1.64% | — |
| 25 | C CORCEPT THERAPEUTICS INC | $11.5M | 100.0K | 1.48% | — |
| 26 | A ABIVAX SA | $11.3M | 114.6K | 1.45% | — |
| 27 | P VAXCYTE INC | $11.3M | 197.8K | 1.44% | — |
| 28 | P VAXCYTE INC | $8.7M | 153.1K | 1.12% | — |
| 29 | M MODERNA INC | $8.6M | 44.4K | 1.10% | — |
| 30 | S SPDR SERIES TRUST | $7.9M | 50.0K | 1.01% | — |
| 31 | L LIQUIDIA CORPORATION | $7.8M | 257.2K | 1.00% | — |
| 32 | B BRIDGEBIO PHARMA INC | $6.8M | 104.0K | 0.88% | — |
| 33 | I IMMUNOCORE HLDGS PLC | $6.7M | 221.8K | 0.86% | — |
| 34 | F 4D MOLECULAR THERAPEUTICS IN | $6M | 421.1K | 0.77% | — |
| 35 | Q UNIQURE NV | $5.7M | 235.4K | 0.73% | — |
| 36 | C CORBUS PHARMACEUTICALS HLDGS | $5.5M | 800.0K | 0.70% | — |
| 37 | V VIRIDIAN THERAPEUTICS INC | $5.3M | 257.1K | 0.68% | — |
| 38 | Q UNIQURE NV | $4.8M | 199.3K | 0.62% | — |
| 39 | C CAPRICOR THERAPEUTICS INC | $4.7M | 497.3K | 0.60% | — |
| 40 | C CAPRICOR THERAPEUTICS INC | $4.6M | 484.4K | 0.59% | — |
| 41 | L LIQUIDIA CORPORATION | $4.5M | 150.0K | 0.58% | — |
| 42 | J JOHNSON & JOHNSON | $4.5M | 17.0K | 0.58% | — |
| 43 | B BIOHAVEN LTD | $4.2M | 317.0K | 0.54% | — |
| 44 | I INDIVIOR PHARMACEUTICALS INC | $4.2M | 117.5K | 0.54% | — |
| 45 | P VAXCYTE INC | $4.1M | 72.8K | 0.53% | — |
| 46 | Q REPLIMUNE GROUP INC | $4M | 305.0K | 0.52% | — |
| 47 | R ARCUS BIOSCIENCES INC | $4M | 153.8K | 0.51% | — |
| 48 | V VOR BIOPHARMA INC | $3.8M | 200.0K | 0.49% | — |
| 49 | K KODIAK SCIENCES INC | $3.7M | 39.0K | 0.47% | — |
| 50 | L LIQUIDIA CORPORATION | $3.6M | 120.0K | 0.47% | — |